Dec 09, 2009 8:45am EST

Immunovaccine Receives Clearance From FDA to Proceed With Phase 1 Clinical Trial for Its Therapeutic Cancer Vaccine

Nov 23, 2009 8:45am EST

Immunovaccine Licenses Vaccine Platform to Pfizer Animal Health

Nov 10, 2009 8:45am EST

Immunovaccine Inc. Signs Collaboration Agreement with National Cancer Institute

Nov 02, 2009 2:33pm EST

Immunovaccine Inc. Signs Cato Research Canada, Inc. as Clinical Trial CRO

Oct 29, 2009 9:10am EDT

Immunovaccine Expands Collaboration with Defence Research & Development Canada

Oct 22, 2009 4:22pm EDT

Immunovaccine Inc. Revises Escrow Securities Schedule

Oct 05, 2009 9:38am EDT

Immunovaccine Inc. Begins Trading on the TSX-V Under the Symbol "IMV"